MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Net income (loss)-$220,474K Fanapt$117,302K Hetlioz$71,431K PONVORY$27,372K Income (loss) beforeincome taxes-$138,647K Provision (benefit) forincome taxes$81,827K Other income, net$12,521K Net product sales$216,105K Loss from operations-$151,168K Total revenues$216,105K Total operatingexpenses$367,273K Selling, general andadministrative$237,951K Research and development$109,271K Cost of goods soldexcluding amortization$13,044K Intangible assetamortization$7,007K
Income Statement
source: myfinsight.com

Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Inc. (VNDA)